Sarcopenia is associated with an increased inflammatory response to surgery in colorectal cancer

Clinical Nutrition

Volumn 35, Issue 4, 2016, Pages 924-927

  Reisinger, Kostan W ^a   Derikx, Joep P M ^a   van Vugt, Jeroen L A ^b   Von Meyenfeldt, Maarten F ^a   Hulsewé, Karel W ^c   Olde Damink, Steven W M ^a   Stoot, Jan H M B ^c   Poeze, Martijn ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c Zuyderland Medical Centre   (Netherlands)

Author keywords

Colorectal surgery; Complications; Inflammation; Sarcopenia

Indexed keywords

C REACTIVE PROTEIN; CALGRANULIN; INTERLEUKIN 6; IL6 PROTEIN, HUMAN;

AGED; ARTICLE; COLORECTAL CANCER; COLORECTAL SURGERY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; ELECTIVE SURGERY; FEMALE; HOSPITAL READMISSION; HUMAN; IMAGE ANALYSIS; INCIDENCE; INFLAMMATION; LENGTH OF STAY; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUSCLE MASS; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PROTEIN BLOOD LEVEL; SARCOPENIA; SKELETAL MUSCLE; BLOOD; BODY MASS; COLORECTAL TUMOR; COMPLICATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RISK FACTOR; X-RAY COMPUTED TOMOGRAPHY;

AGED; BODY MASS INDEX; C-REACTIVE PROTEIN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; INFLAMMATION; INTERLEUKIN-6; LENGTH OF STAY; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; MUSCLE, SKELETAL; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK FACTORS; SARCOPENIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84937621952     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2015.07.005     Document Type: Article

References (29)

1. Tan K.Y., Kawamura Y.J., Tokomitsu A, Tang T Assessment for frailty is useful for predicting morbidity in elderly patients undergoing colorectal cancer resection whose comorbidities are already optimized. Am J Surg 2012, 204:139-143.
2. Robinson T.N., Wu D.S., Stiegmann G.V., Moss M. Frailty predicts increased hospital and six-month healthcare cost following colorectal surgery in older adults. Am J Surg 2011, 202:511-514.
3. Reisinger K.W., van Vugt J.L., Tegels J.J., Snijders C, Hulsewe K.W., Hoofwijk A.G., et al. Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. Ann Surg 2015, 261:345-352.
4. Fried L.P., Hadley E.C., Walston J.D., Newman A.B., Guralnik J.M., Studenski S, et al. From bedside to bench: research agenda for frailty. Sci Aging Knowledge Environ 2005, 2005:pe24.
5. Lieffers J.R., Bathe O.F., Fassbender K., Winget M., Baracos V.E. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 2012, 107:931-936.
6. van Vledder M.G., Levolger S., Ayez N., Verhoef C., Tran T.C., Ijzermans J.N. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 2012, 99:550-557.
7. Muscaritoli M., Anker S.D., Argiles J., Aversa Z., Bauer J.M., Biolo G., et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr 2010, 29:154-159.
8. Scheede-Bergdahl C., Watt H.L., Trutschnigg B., Kilgour R.D., Haggarty A., Lucar E., et al. Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia?. Clin Nutr 2012, 31:85-88.
9. Keller D.S., Chien H.L., Hashemi L., Senagore A.J., Delaney C.P. The HARM score: a novel, easy measure to evaluate quality and outcomes in colorectal surgery. Ann Surg 2014, 259:1119-1125.
10. van Dielen F.M., van't Veer C., Schols A.M., Soeters P.B., Buurman W.A., Greve J.W. Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int J Obes Relat Metab Disord 2001, 25:1759-1766.
11. Steinbakk M., Naess-Andresen C.F., Lingaas E., Dale I., Brandtzaeg P., Fagerhol M.K. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 1990, 336:763-765.
12. Fagerhol M.K. Calprotectin, a faecal marker of organic gastrointestinal abnormality. Lancet 2000, 356:1783-1784.
13. Strassmann G., Fong M., Kenney J.S., Jacob C.O. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 1992, 89:1681-1684.
14. Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999, 340:448-454.
15. Hanssen S.J., Derikx J.P., Vermeulen Windsant I.C., Heijmans J.H., Koeppel T.A., Schurink G.W., et al. Visceral injury and systemic inflammation in patients undergoing extracorporeal circulation during aortic surgery. Ann Surg 2008, 248:117-125.
16. Richards C.H., Roxburgh C.S., MacMillan M.T., Isswiasi S., Robertson E.G., Guthrie G.K., et al. The relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer. PLoS One 2012, 7:e41883.
17. Windsor J.A., Hill G.L. Protein depletion and surgical risk. Aust N Z J Surg 1988, 58:711-715.
18. Deans D.A., Tan B.H., Wigmore S.J., Ross J.A., de Beaux A.C., Paterson-Brown S., et al. The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. Br J Cancer 2009, 100:63-69.
19. Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., Boirie Y., Cederholm T., Landi F., et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in older people. Age Ageing 2010, 39:412-423.
20. Kim J.K., Choi S.R., Choi M.J., Kim S.G., Lee Y.K., Noh J.W., et al. Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr 2014, 33:64-68.
21. Platt J.J., Ramanathan M.L., Crosbie R.A., Anderson J.H., McKee R.F., Horgan P.G., et al. C-reactive protein as a predictor of postoperative infective complications after curative resection in patients with colorectal cancer. Ann Surg Oncol 2012, 19:4168-4177.
22. Lagoutte N., Facy O., Ravoire A., Chalumeau C., Jonval L., Rat P., et al. C-reactive protein and procalcitonin for the early detection of anastomotic leakage after elective colorectal surgery: pilot study in 100 patients. J Visc Surg 2012, 149:e345-e349.
23. Ryan A.M., Reynolds J.V., Healy L., Byrne M., Moore J., Brannelly N., et al. Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial. Ann Surg 2009, 249:355-363.
24. Yuill K.A., Richardson R.A., Davidson H.I., Garden O.J., Parks R.W. The administration of an oral carbohydrate-containing fluid prior to major elective upper-gastrointestinal surgery preserves skeletal muscle mass postoperatively-a randomised clinical trial. Clin Nutr 2005, 24:32-37.
25. Martin L., Birdsell L., Macdonald N., Reiman T., Clandinin M.T., McCargar L.J., et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 2013, 31:1539-1547.
26. Miyamoto Y., Baba Y., Sakamoto Y., Ohuchi M., Tokunaga R., Kurashige J., et al. Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Onol 2015, Epub ahead of print.
27. Barret M., Antoun S., Dalban C., Malka D., Mansourbakht T., Zaanan A., et al. Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer. Nutr Cancer 2014, 66:583-589.
28. Guthrie G.J., Charles K.A., Roxburgh C.S., Horgan P.G., McMillan D.C., Clarke S.J. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol 2013, 88:218-230.
29. Evans W.J. Protein nutrition, exercise and aging. J Am Coll Nutr 2004, 23:601S-609S.